PE20131303A1 - Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos - Google Patents

Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos

Info

Publication number
PE20131303A1
PE20131303A1 PE2009001215A PE2009001215A PE20131303A1 PE 20131303 A1 PE20131303 A1 PE 20131303A1 PE 2009001215 A PE2009001215 A PE 2009001215A PE 2009001215 A PE2009001215 A PE 2009001215A PE 20131303 A1 PE20131303 A1 PE 20131303A1
Authority
PE
Peru
Prior art keywords
oxo
group
dihydroxyandrostanes
carbolactones
pregn
Prior art date
Application number
PE2009001215A
Other languages
English (en)
Inventor
Carsten Seilz
Hartmut Seba
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35744678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20131303(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of PE20131303A1 publication Critical patent/PE20131303A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE UN COMPUESTO DE FORMULA III DONDE: R6a ES H, JUNTO CON R7a ES UN GRUPO -CH2; R6b ES H, JUNTO CON R7b ES UN GRUPO -CH2, DOBLE UNION; R7a ES H, ALQUILO C1-C4, ALCOXICARBONILO C1-C4; R7b ES H, JUNTO CON R6b ES UN GRUPO -CH2; R9 ES H, JUNTO CON R11 ES UNA DOBLE UNION; R10 ES H, METILO, ETILO; R11 ES H, JUNTO CON R9 ES UNA DOBLE UNION O FORMA UN GRUPO EPOXI -O-; R13 ES H, METILO, ETILO; R15 ES H, ALQUILO C1-C4, ENTRE OTROS; R16 ES H, JUNTO CON R15 FORMA CH2 O DOBLE UNION, QUE COMPRENDE EN HACER REACCIONAR UN COMPUESTO DE FORMULA I : DONDE R5 ES HIDROXI, R6a, R6b, R7a, R7b, R10, R11, R13, R15, R16 TIENE EL MISMO SIGNIFICADO QUE EN LA FORMULA III, CON POR LO MENOS 3 EQUIVALENTES MOLARES DE UN HIPOCLORITO ORGANICO EN PRESENCIA DE CANTIDADES CATALITICAS DE UN DERIVADO DE N-OXIDO DE 2,2,6,6-TETRAMETILPIPERIDINA-N-OXIDO A UN pH DE POR LO MENOS 8. UN COMPUESTO PREFERIDO ES HEMISOLVATO EN DICLOROMETANO DE 6 BETHA,7BETHA,15BETHA,16BETHA-DIMETILENO-3-OXO-17ALPHA-PREGNAN-5BETHA-OL-21,17-CARBOLACTONA
PE2009001215A 2005-07-21 2006-07-20 Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos PE20131303A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090214.7A EP1746101B2 (de) 2005-07-21 2005-07-21 Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen

Publications (1)

Publication Number Publication Date
PE20131303A1 true PE20131303A1 (es) 2013-11-27

Family

ID=35744678

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2009001215A PE20131303A1 (es) 2005-07-21 2006-07-20 Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos
PE2006000875A PE20070215A1 (es) 2005-07-21 2006-07-20 Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2006000875A PE20070215A1 (es) 2005-07-21 2006-07-20 Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos

Country Status (22)

Country Link
US (2) US20070049747A1 (es)
EP (1) EP1746101B2 (es)
JP (2) JP5345843B2 (es)
CN (1) CN101223186B (es)
AR (1) AR055993A1 (es)
AT (1) ATE403668T1 (es)
CY (1) CY1110411T1 (es)
DE (1) DE502005004948D1 (es)
DK (1) DK1746101T4 (es)
DO (1) DOP2006000172A (es)
ES (1) ES2311927T5 (es)
GT (1) GT200600321A (es)
MY (1) MY147795A (es)
PE (2) PE20131303A1 (es)
PL (1) PL1746101T5 (es)
PT (1) PT1746101E (es)
SI (1) SI1746101T2 (es)
SV (1) SV2007002621A (es)
TW (1) TWI392683B (es)
UA (1) UA100092C2 (es)
UY (1) UY29686A1 (es)
ZA (1) ZA200801674B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE403668T1 (de) * 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
EP2265629B1 (en) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylene-17 carbolactones and related uses
DE102008026793A1 (de) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
EP2266998B1 (en) 2009-06-16 2013-07-24 Crystal Pharma, S.A.U. Process for obtaining 17-spirolactones in steroids
CN101775057B (zh) * 2010-02-09 2014-07-16 浙江仙琚制药股份有限公司 屈螺酮及其中间体的制备方法
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
CN102746370A (zh) * 2011-04-22 2012-10-24 天津金耀集团有限公司 一种氧化合成孕甾11位酮基的新工艺
DE202012013283U1 (de) * 2012-01-13 2015-11-23 Saint-Gobain Glass France Abstandshalter für Isolierverglasungen
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
BR112015025816B1 (pt) * 2013-04-12 2021-02-02 Industriale Chimica S.R.L processo para a preparação de drospirenona
CN104163846A (zh) * 2013-05-17 2014-11-26 上海创诺制药有限公司 一种制备曲螺酮的方法
US10190359B2 (en) 2013-12-12 2019-01-29 Saint-Gobain Glass France Double glazing having improved sealing
WO2015086459A1 (de) 2013-12-12 2015-06-18 Saint-Gobain Glass France Abstandshalter für isolierverglasungen mit extrudiertem dichtprofil
CN104788524B (zh) * 2014-01-16 2016-07-06 浙江仙居君业药业有限公司 一种19-去甲-4-雄甾烯-3,17-二酮的制备方法
TR201815606T4 (tr) 2014-06-27 2018-11-21 Saint Gobain Mesafe parçasına sahip yalıtım cam kaplaması ve bunun imal edilmesi için yöntem ve ayrıca bunun bina cam kaplaması olarak kullanımı.
US10301868B2 (en) 2014-06-27 2019-05-28 Saint-Gobain Glass France Insulated glazing comprising a spacer, and production method
EP3198101B1 (de) 2014-09-25 2018-08-15 Saint-Gobain Glass France Abstandshalter für isolierverglasungen
CA2977207C (en) 2015-03-02 2019-12-31 Saint-Gobain Glass France Glass-fiber-reinforced spacer for insulating glazing unit
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
AU2016282863B2 (en) 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069219A (en) 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
DE3026783C2 (de) 1980-07-11 1982-07-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5β-Hydroxy-δ↑6↑-steroiden
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
EP0075189B1 (en) 1981-09-21 1985-08-28 Schering Aktiengesellschaft 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
US5106995A (en) 1989-05-05 1992-04-21 Isp Investments Inc. Production of lactones from diols
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE60308388T2 (de) * 2002-08-16 2007-09-20 Pharmacia & Upjohn Co. Llc, Kalamazoo 5-Androsten-3beta-ol-Steroide und Verfahren für ihre Herstellung
JP2005027184A (ja) * 2003-07-04 2005-01-27 Seiko Epson Corp 高周波複合部品
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ATE403668T1 (de) * 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
US7319154B2 (en) * 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
US20080032147A1 (en) * 2005-08-26 2008-02-07 Thomas Neel Medium density fibreboard

Also Published As

Publication number Publication date
JP2013177450A (ja) 2013-09-09
DE502005004948D1 (de) 2008-09-18
US20110275796A1 (en) 2011-11-10
JP5345843B2 (ja) 2013-11-20
US8658788B2 (en) 2014-02-25
ATE403668T1 (de) 2008-08-15
DOP2006000172A (es) 2007-02-15
US20070049747A1 (en) 2007-03-01
DK1746101T4 (da) 2014-08-11
DK1746101T3 (da) 2008-11-24
EP1746101A1 (de) 2007-01-24
SI1746101T2 (sl) 2014-09-30
PL1746101T3 (pl) 2009-01-30
EP1746101B2 (de) 2014-05-14
UA100092C2 (en) 2012-11-12
JP2009501753A (ja) 2009-01-22
TWI392683B (zh) 2013-04-11
ES2311927T3 (es) 2009-02-16
CN101223186B (zh) 2012-09-05
UY29686A1 (es) 2007-02-28
CN101223186A (zh) 2008-07-16
GT200600321A (es) 2007-02-23
MY147795A (en) 2013-01-31
CY1110411T1 (el) 2015-04-29
PL1746101T5 (pl) 2014-11-28
EP1746101B1 (de) 2008-08-06
PT1746101E (pt) 2008-10-27
TW200716660A (en) 2007-05-01
AR055993A1 (es) 2007-09-12
ZA200801674B (en) 2009-08-26
ES2311927T5 (es) 2014-09-08
PE20070215A1 (es) 2007-04-11
SI1746101T1 (sl) 2009-02-28
SV2007002621A (es) 2007-12-12

Similar Documents

Publication Publication Date Title
PE20131303A1 (es) Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos
PH12013500365A1 (en) Anti-infective agents and uses thereof
PE20061447A1 (es) Tigeciclina y metodos para preparar 9-aminominociclina
RS52759B (en) PROCEDURE FOR THE PREPARATION OF CYCLOalkylcarboxyamide-benzoic acids
MXPA05009756A (es) Proceso para preparar ditioesteres.
ES2531190T3 (es) Método para producir un compuesto de 4-oxoquinolina
EP2428519A3 (en) Process for the preparation of 17-vinyl- triflates as intermediates
WO2008012733A3 (en) Method and composition for permanently shaping hair
ZA200702700B (en) Diagnostic compounds
RS54031B1 (en) IMPROVED METHOD FOR SYNTHESIS OF PIRFENIDONE
AR060174A1 (es) Un proceso para preparar derivados de tetrahidroquinolina
MY155733A (en) Early strengthening agent for hydraulic composition
TW200640914A (en) Novel processes for the preparation of a benzofuran
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
EP2388002A3 (en) Antidepressant containing heterocyclic compound having specific structure
CO5031242A1 (es) Derivados de cromanona y tiocromanona, proceso para su preparacion y composicion farmaceutica que los comprende
ECSP077228A (es) Proceso para la preparación de derivados de estrona y de estradiol sustituidos en la posición 2
NO20064332L (no) Farmasoytisk akseptable salter av clopidogrel
AR074863A1 (es) Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc
HRP20160853T1 (hr) Postupak za proizvodnju 3-okso-pregn-4-en-21,17-karbolaktona pomoću bezmetalne oksidacije 17-(3-hidroksipropil)-3,17-dihidroksiandrostana
MY138185A (en) Emulsfiers for drilling fluids
EP2865678A3 (en) Crystalline hemi-tartrate form of a benzoimidazol-2-yl pyrimidine derivative
TW200632091A (en) Liquid detergent composition
ES2191963T3 (es) Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica

Legal Events

Date Code Title Description
FG Grant, registration